Innovative Product Portfolio Scanadu offers a unique portfolio of innovative medical devices for consumers, including the Scout™ and a urine test kit. These products are designed to provide accurate physiological measurements and empower individuals to monitor their health from the comfort of their homes, presenting an opportunity for direct-to-consumer sales.

Venture-Backed Success As a venture-backed company that raised $35 million in Series B funding, Scanadu has the financial backing necessary to scale its operations and bring its FDA-cleared products to market. This financial stability positions the company as a reliable partner for potential bulk purchases or distribution agreements.

Quantified Personalized Medicine Scanadu's long-term vision of combining various sensors with intelligent algorithms to enable personalized medicine aligns with the growing trend of personalized healthcare solutions. This focus on data-driven healthcare presents an opportunity for partnerships with healthcare providers or insurers looking to offer advanced diagnostic tools to their clients.

Reputable Industry Recognition Being selected as one of the top 10 finalists for the Qualcomm Tricorder XPRIZE competition signifies Scanadu's expertise and innovative approach in the medical technology sector. This industry recognition can be leveraged to build credibility and open doors for collaborations with other healthcare technology leaders.

Expansion & Market Penetration With a strong technology stack and a vision for broad sensor integration, Scanadu is well-positioned for expansion into new markets and product lines. This potential for diversification creates opportunities for strategic partnerships or reseller agreements to penetrate untapped markets with Scanadu's cutting-edge products.